These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Epidemiology, clinical characteristics, and management of AIDS-related lymphoma. Levine AM Hematol Oncol Clin North Am; 1991 Apr; 5(2):331-42. PubMed ID: 2022597 [TBL] [Abstract][Full Text] [Related]
6. Management of AIDS-related lymphoma. Levine AM Curr Opin Oncol; 2008 Sep; 20(5):522-8. PubMed ID: 19106654 [TBL] [Abstract][Full Text] [Related]
7. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients]. Corti M; VillafaƱe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446 [TBL] [Abstract][Full Text] [Related]
8. HIV infection and AIDS. Lloyd A P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558 [TBL] [Abstract][Full Text] [Related]
9. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era. Cingolani A; Fratino L; Scoppettuolo G; Antinori A J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454 [TBL] [Abstract][Full Text] [Related]
11. The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era? Clayton A; Mughal T Hematol Oncol; 2004 Sep; 22(3):111-20. PubMed ID: 15991221 [TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
13. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT; Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647 [TBL] [Abstract][Full Text] [Related]
14. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628 [TBL] [Abstract][Full Text] [Related]
16. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411 [TBL] [Abstract][Full Text] [Related]
17. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399 [TBL] [Abstract][Full Text] [Related]
18. New aspects in the treatment of AIDS-related lymphoma. Schmidt-Wolf IG; Rockstroh JK; Schlegel U; Pels H; Weiss R; Huhn D Eur J Med Res; 2002 Jul; 7(7):295-303. PubMed ID: 12176678 [TBL] [Abstract][Full Text] [Related]
20. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy. Palmieri C; Treibel T; Large O; Bower M QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]